Balanced Rock Investment Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$313K Buy
340
+34
+11% +$34.5K 0.22% 81
2025
Q4
$329K Buy
306
+16
+6% +$15.3K 0.23% 80
2025
Q3
$221K Buy
290
+14
+5% +$10.4K 0.16% 92
2025
Q2
$215K Sell
276
-1
-0.4% -$777 0.17% 93
2025
Q1
$229K Sell
277
-16
-5% -$13.3K 0.18% 81
2024
Q4
$226K Sell
293
-15
-5% -$12.4K 0.18% 82
2024
Q3
$273K Sell
308
-26
-8% -$23.4K 0.21% 76
2024
Q2
$302K Sell
334
-28
-8% -$22.4K 0.25% 68
2024
Q1
$282K Sell
362
-139
-28% -$98.9K 0.24% 77
2023
Q4
$292K Buy
+501
New +$292K 0.26% 82

Other funds holding LLY

Balanced Rock Investment Advisors's LLY Position: Q1 2026 in Review

Balanced Rock Investment Advisors increased its Eli Lilly (LLY) stake by 11% in Q1 2026, buying an estimated $34.5K and bringing the position to 340 shares worth $313K. The position accounts for 0.22% of the portfolio, ranked #81.

Balanced Rock Investment Advisors first reported a position in LLY in Q4 2023 and has held it in 10 quarters since. The position peaked at $329K in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Balanced Rock Investment Advisors held 340 shares of Eli Lilly worth $313K as of Q1 2026.
  • Balanced Rock Investment Advisors bought 34 Eli Lilly shares in Q1 2026, an estimated $34.5K.
  • Eli Lilly made up 0.22% of Balanced Rock Investment Advisors's portfolio in Q1 2026, its #81 holding.
  • Balanced Rock Investment Advisors first reported a position in Eli Lilly in Q4 2023 and has held it in 10 quarters since.
  • Balanced Rock Investment Advisors's Eli Lilly position peaked at $329K in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Balanced Rock Investment Advisors's 13F filing for Q1 2026, filed 13 May 2026.